Shares of Abbott India declined 2.04% to Rs 30,260. The stock is a constituent of the Nifty Midcap 150 index.
Here's a look at Abbott India's recent financial performance:
Abbott India - Key Financials (Standalone)
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
| Sales | Rs 1,738 Crore | Rs 1,604 Crore | Rs 1,614 Crore | Rs 1,632 Crore | Rs 1,557 Crore |
| Other Income | Rs 72 Crore | Rs 76 Crore | Rs 71 Crore | Rs 60 Crore | Rs 67 Crore |
| Total Income | Rs 1,811 Crore | Rs 1,680 Crore | Rs 1,686 Crore | Rs 1,693 Crore | Rs 1,624 Crore |
| Total Expenditure | Rs 1,312 Crore | Rs 1,193 Crore | Rs 1,196 Crore | Rs 1,211 Crore | Rs 1,184 Crore |
| EBIT | Rs 498 Crore | Rs 486 Crore | Rs 489 Crore | Rs 481 Crore | Rs 439 Crore |
| Interest | Rs 5 Crore | Rs 3 Crore | Rs 2 Crore | Rs 2 Crore | Rs 2 Crore |
| Tax | Rs 127 Crore | Rs 115 Crore | Rs 126 Crore | Rs 120 Crore | Rs 109 Crore |
| Net Profit | Rs 365 Crore | Rs 367 Crore | Rs 360 Crore | Rs 358 Crore | Rs 328 Crore |
The quarterly sales for June 2025 stood at Rs 1,738 crore, up from Rs 1,604 crore in March 2025. The net profit for June 2025 was Rs 365 crore compared to Rs 367 crore in March 2025.
Abbott India - Key Financials (Annual, Standalone)
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
| Sales | Rs 6,409 Crore | Rs 5,848 Crore | Rs 5,348 Crore | Rs 4,919 Crore | Rs 4,310 Crore |
| Other Income | Rs 275 Crore | Rs 248 Crore | Rs 154 Crore | Rs 77 Crore | Rs 80 Crore |
| Total Income | Rs 6,684 Crore | Rs 6,097 Crore | Rs 5,502 Crore | Rs 4,996 Crore | Rs 4,390 Crore |
| Total Expenditure | Rs 4,786 Crore | Rs 4,466 Crore | Rs 4,213 Crore | Rs 3,897 Crore | Rs 3,446 Crore |
| EBIT | Rs 1,898 Crore | Rs 1,630 Crore | Rs 1,289 Crore | Rs 1,098 Crore | Rs 944 Crore |
| Interest | Rs 11 Crore | Rs 12 Crore | Rs 15 Crore | Rs 19 Crore | Rs 18 Crore |
| Tax | Rs 472 Crore | Rs 416 Crore | Rs 324 Crore | Rs 281 Crore | Rs 235 Crore |
| Net Profit | Rs 1,414 Crore | Rs 1,201 Crore | Rs 949 Crore | Rs 798 Crore | Rs 690 Crore |
The annual sales for the year-ending March 2025 increased to Rs 6,409 Crore from Rs 5,848 Crore in March 2024. The net profit for the year-ending March 2025 also increased to Rs 1,414 Crore compared to Rs 1,201 Crore in March 2024.
Key Financial Ratios
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
| Basic EPS (Rs.) | 665.62 | 565.28 | 446.78 | 375.86 | 325.04 |
| Diluted Eps (Rs.) | 665.62 | 565.28 | 446.78 | 375.86 | 325.04 |
| Book Value [Excl. Reval Reserve]/Share (Rs.) | 1,992.07 | 1,740.65 | 1,500.49 | 1,326.96 | 1,224.55 |
| Dividend/Share (Rs.) | 475.00 | 410.00 | 325.00 | 275.00 | 275.00 |
| Face Value | 10 | 10 | 10 | 10 | 10 |
The company's basic and diluted EPS for the year-ending March 2025 was Rs 665.62, compared to Rs 565.28 in March 2024. The dividend per share stood at Rs 475.00 for March 2025.
Abbott India announced a final dividend of Rs 475 per share, effective from July 25, 2025. Other corporate actions include newspaper publications and notices of postal ballots.
Moneycontrol analysis, as of September 12, 2025, suggests a bearish sentiment on the stock.
Shares of Abbott India were last traded at Rs 30,260.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
